The secretion of gonadotrophins, insulin and insulin-like growth factor 1 by Merino rams supplemented with different legume seeds

1996 ◽  
Vol 47 (6) ◽  
pp. 843 ◽  
Author(s):  
D Blache ◽  
DW Miller ◽  
JTB Milton ◽  
GB Martin

Supplementing mature rams with lupin seed (Lupinus angustifolius, a highly digestible source of energy and protein) increases gonadotrophin secretion within 5-10 days. When sheep receive a post-ruminal supplement of protein and energy equivalent to that in the lupin supplement, LH secretion is increased but not to the same extent as with lupin seed itself. This suggests that lupin seed contains a specific mixture of nutrients or an unknown component that exerts effects on the brain centres that control gonadotrophin secretion. This hypothesis was tested by comparing the responses to isonitrogenous and isoenergetic supplements of 3 legumes: lupins, cowpeas, and soybeans. Rams were fed the supplements for 10 days and blood was sampled every 20 min for 24 h on days -1, 5, and 10 relative to the start of supplementation. The plasma was assayed for LH, FSH, and the metabolic hormones insulin and insulin-like growth factor 1 (IGF-1). Both the cowpea and the lupin supplements increased LH pulse frequency and the mean concentrations of insulin and IGF-1 on days 5 and 10 compared with day -1 (P < 0.05). The soybean supplement did not affect LH pulse frequency or the concentrations of insulin or IGF-1. Only the cowpea supplement increased the mean concentration of FSH. The nutritional stimulation of the reproductive centres of the brain appears not to be specific to lupins, because the diet supplemented with cowpeas evoked similar responses. The lack of response to soybean seed suggests that the effects of diet on secretion of metabolic and gonadotrophic hormones are not due simply to the total energy and protein content of the diets, but to subtle differences in their chemical constituents.

1991 ◽  
Vol 128 (2) ◽  
pp. 197-204 ◽  
Author(s):  
F. J. Ballard ◽  
S. E. Knowles ◽  
P. E. Walton ◽  
K. Edson ◽  
P. C. Owens ◽  
...  

ABSTRACT Incubation of 125I-labelled insulin-like growth factor-I (IGF-I) with rat plasma at 4 °C led to the transfer of approximately half the radioactivity to 150 kDa and smaller complexes with IGF-binding proteins. The extent of association was greater with labelled IGF-II and essentially absent with the truncated IGF-I analogue, des(1–3)IGF-I. A greater degree of binding of IGF peptides with binding proteins occurred after i.v. injection of the tracers into rats, but most of the des(1–3)IGF-I radioactivity remained free. Measurement of the total plasma clearances showed the rapid removal of des(1–3)IGF-I compared with IGF-I and IGF-II; the mean clearances were 4·59, 1·20 and 1·34 ml/min per kg respectively. The mean steadystate volume of distribution was larger for des(1–3)IGF-I than for IGF-I and IGF-II (461, 167 and 181 ml/kg respectively), probably because of the differences in plasma protein binding. With all tracers, radioactivity appeared in the kidneys to a greater extent than in other organs. The amount of radioactivity found in the adrenals, brain, skin, stomach, duodenum, ileum plus jejunum and colon was in rank order, des(1–3)IGF-I > IGF-I > IGF-II. Since this ranking is the opposite of the abilities of the three IGF peptides to form complexes with plasma binding proteins, we propose that the plasma binding proteins inhibit the transfer of the growth factors to their tissue sites of action. Moreover, we suggest that IGF analogues that are cleared rapidly from blood may have greater biological potencies in vivo. Journal of Endocrinology (1991) 128, 197–204


2001 ◽  
Vol 37 (1-3) ◽  
pp. 320-334 ◽  
Author(s):  
Gloria Patricia Cardona-Gómez ◽  
Pablo Mendez ◽  
Lydia L DonCarlos ◽  
Iñigo Azcoitia ◽  
Luis M Garcia-Segura

2002 ◽  
Vol 83 (1-5) ◽  
pp. 211-217 ◽  
Author(s):  
Gloria Patricia Cardona-Gómez ◽  
Pablo Mendez ◽  
Lydia L. DonCarlos ◽  
Iñigo Azcoitia ◽  
Luis M. Garcia-Segura

2017 ◽  
Vol 114 (36) ◽  
pp. 9731-9736 ◽  
Author(s):  
Rigo Cintron-Colon ◽  
Manuel Sanchez-Alavez ◽  
William Nguyen ◽  
Simone Mori ◽  
Ruben Gonzalez-Rivera ◽  
...  

When food resources are scarce, endothermic animals can lower core body temperature (Tb). This phenomenon is believed to be part of an adaptive mechanism that may have evolved to conserve energy until more food becomes available. Here, we found in the mouse that the insulin-like growth factor 1 receptor (IGF-1R) controls this response in the central nervous system. Pharmacological or genetic inhibition of IGF-1R enhanced the reduction of temperature and of energy expenditure during calorie restriction. Full blockade of IGF-1R affected female and male mice similarly. In contrast, genetic IGF-1R dosage was effective only in females, where it also induced transient and estrus-specific hypothermia in animals fed ad libitum. These effects were regulated in the brain, as only central, not peripheral, pharmacological activation of IGF-1R prevented hypothermia during calorie restriction. Targeted IGF-1R knockout selectively in forebrain neurons revealed that IGF signaling also modulates calorie restriction-dependent Tbregulation in regions rostral of the canonical hypothalamic nuclei involved in controlling body temperature. In aggregate, these data identify central IGF-1R as a mediator of the integration of nutrient and temperature homeostasis. They also show that calorie restriction, IGF-1R signaling, and body temperature, three of the main regulators of metabolism, aging, and longevity, are components of the same pathway.


2009 ◽  
Vol 111 (1) ◽  
pp. 164-170 ◽  
Author(s):  
Lauren Fletcher ◽  
Sanjivan Kohli ◽  
Shane M. Sprague ◽  
Robert A. Scranton ◽  
Stuart A. Lipton ◽  
...  

Object Individually, the cytokines erythropoietin (EPO) and insulin-like growth factor–I (IGF-I) have both been shown to reduce neuronal damage significantly in rodent models of cerebral ischemia. The authors have previously shown that EPO and IGF-I, when administered together, provide acute and prolonged neuroprotection in cerebrocortical cultures against N-methyl-d-aspartate–induced apoptosis. The aim of this study was to determine whether intranasally applied EPO plus IGF-I can provide acute neuroprotection in an animal stroke model and to show that intranasal administration is more efficient at delivering EPO plus IGF-I to the brain when compared with intravenous, subcutaneous, or intraperitoneal administration. Methods The EPO and IGF-I were administered intranasally to mice that underwent transient middle cerebral artery occlusion (MCAO). Stroke volumes were measured after 1 hour of MCAO and 24 hours of reperfusion. To evaluate the long-term effects of this treatment, behavioral outcomes were assessed at 3, 30, 60, and 90 days following MCAO. Radiography and liquid scintillation were used to visualize and quantify the uptake of radiolabeled 125I-EPO and 125I–IGF-I into the mouse brain after intranasal, intravenous, subcutaneous, or intraperitoneal administration. Results Intranasal administration of EPO plus IGF-I reduced stroke volumes within 24 hours and improved neurological function in mice up to 90 days after MCAO. The 125I-EPO and 125I–IGF-I were found in the brain within 20 minutes after intranasal administration and accumulated within the injured areas of the brain. In addition, intranasal administration delivered significantly higher levels of the applied 125I-EPO and 125I–IGF-I to the brain compared with intravenous, subcutaneous, or intraperitoneal administration. Conclusions The data demonstrate that intranasal EPO plus IGF-I penetrates into the brain more efficiently than other drug delivery methods and could potentially provide a fast and efficient treatment to prevent chronic effects of stroke.


2000 ◽  
Vol 20 (8) ◽  
pp. 2926-2933 ◽  
Author(s):  
Eva Carro ◽  
Angel Nuñez ◽  
Svetlana Busiguina ◽  
Ignacio Torres-Aleman

Sign in / Sign up

Export Citation Format

Share Document